Blankenship K. et al. (2011)
Guanfacine, extended, release, two, patients, pervasive, developmental, disorders
Journal of Child and Adolescent Psychopharmacology
21(3), pp. 287-290
Bowers K. , Lin P. , Erickson C. A. (2015)
Pharmacogenomic medicine in autism: Challenges and opportunities.
Pediatric Drugs
April, 17(2), pp. 115-124.
Early M. C. et al. (2012)
Case report: 16-year-old male with autistic disorder with preoccupation with female feet.
Journal of Autism and Developmental Disorders
May, 42(6), pp. 1133-1137.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-90.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-89.
Erickson C. A. et al. (2011)
An open-label naturalistic pilot study of acamprosate in youth with autistic disorder
Journal of Child and Adolescent Psychopharmacology
Erickson C. A. et al. (2010)
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics
7(3), pp. 258-263
Erickson C. A. , Mullett J. , McDougle C. J. (2010)
Brief report: acamprosate in fragile X syndrome.
Journal of Autism and Developmental Disorders
40(11), pp. 1412-1416.
Erickson C. A. et al. (2014)
Journal of Autism and Developmental Disorders
April, 44(4), pp. 981-987.
Erickson C. A. et al. (2005)
Gastrointestinal factors in autistic disorder: a critical review.
Journal of Autism and Developmental Disorders
35(6), pp. 713-727
Erickson C. A. , Chambers J. (2006)
Memantine for disruptive behavior in autistic disorder.
Journal of Clinical Psychiatry
67(6), pp. 1000
Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)
Open-label memantine in fragile X syndrome.
Journal of Autism and Developmental Disorders
39(12), pp. 1629-1635.
Erickson C. A. et al. (2014)
STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.
Journal of Autism and Developmental Disorders
44(4), pp. 958-964.
Fitzpatrick S. E. et al. (2016)
Aggression in autism spectrum disorder: presentation and treatment options.
Neuropsychiatric Disease and Treatment
2016(12), pp. 1525-1538
Kowalski J. et al. (2011)
Paliperidone palmitate in a child with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
October, 21(5), pp. 491-493